Drug interactions in transplant patients: what everyone should know

Authors:
  • EMErin McCann
    Erin McCann
  • SLSabrina Lee
    Sabrina Lee
  • MWMatthew R Weir
    Matthew R Weir

Abstract
Adverse events due to drug-drug interactions remain a challenge in the postsurgical care of transplant recipients. A combination of potent and selective immunosuppressive drugs, which have a narrow therapeutic index, with medications for the treatment of comorbidities such as dyslipidemia, infection, psychiatric conditions, and hypertension, can lead to life-threatening drug-drug interactions. There are a number of important drug-drug interactions which are important for physicians to consider. It is critical to understand the pharmacodynamics and pharmacokinetics of drug-drug interactions, their potential impact on patient care, and the management strategies. Close therapeutic drug monitoring and evaluation of drug-specific side effects continue to be an important key to minimize adverse events due to drug-drug interactions.

This publication has 105 references indexed in Scilit: